Sign up to save your podcasts
Or
Share E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449
View all episodes
By Michael Putman
4.9
111111 ratings
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
323 Listeners
JAMA Clinical Reviews
501 Listeners
Rheumnow Podcast
124 Listeners
The Curbsiders Internal Medicine Podcast
3,339 Listeners
Core IM | Internal Medicine Podcast
1,141 Listeners
Healio Rheuminations
122 Listeners
Annals On Call Podcast
190 Listeners
The Clinical Problem Solvers
514 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
366 Listeners
Freely Filtered, a NephJC Podcast
169 Listeners
ACR on Air
68 Listeners
Around the Rheum
4 Listeners
Rheumatology For The Royal College
181 Listeners
Talking Rheumatology Spotlight
6 Listeners
ACR Journals On Air
18 Listeners